Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.

Leukemia · 2026 · PMC12789001 · PMID 41233549

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

showed a trendp = 0.16not close (p > 0.1)

The <1 year or >9 years group showed a trend toward improved OS (HR 0.43; 95% CI 0.13–1.42, p = 0.16) (Supplementary Fig. 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.